The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

VER VERNALIS PLC ORD 1P




 Page 1 of 3

| 1 | 2 | 3 | Next

Time/Date Code Headline Source Impact
07:00 29-Apr-2016 VER Total Voting Rights RNS -0.85% Down
16:40 27-Apr-2016 VER Holding(s) in Company RNS -1.37% Down
17:17 26-Apr-2016 VER Posting of Circular and Notice of General Meeting RNS -1.21% Down
11:00 26-Apr-2016 VER Vernalis plc to raise 40 million in Placing RNS -1.21% Down
14:26 21-Apr-2016 VER Sandford Sommer appointed as President & COO in US RNS -1.42% Down
07:00 14-Apr-2016 VER Vernalis Announce CCP-07 Multiple-Dose Results RNS -0.15% Down
07:00 13-Apr-2016 VER Vernalis Announce CCP-08 Single-Dose Study Results RNS +0.69% Up
09:00 31-Mar-2016 VER Total Voting Rights RNS -1.30% Down
13:55 29-Mar-2016 VER Blocklisting Interim Review RNS -0.08% Down
13:06 18-Mar-2016 VER Holding(s) in Company RNS -9.01% Down
07:00 17-Mar-2016 VER Unaudited interim results for 6 months to 31/12/15 RNS -11.22% Down
15:34 04-Feb-2016 VER Notice of Results for Six Months Ended 31/12/2015 RNS -2.37% Down
14:36 19-Jan-2016 VER Holding(s) in Company RNS -0.94% Down
07:00 06-Jan-2016 VER Vernalis Announces Adenosine Antagonist Licensee RNS -7.96% Down
07:00 31-Dec-2015 VER Total Voting Rights RNS -0.31% Down
07:00 21-Dec-2015 VER Vernalis Announce CCP-07 Single-Dose Study Results RNS -0.81% Down
17:19 03-Dec-2015 VER Launch of 2015 Sharesave Plan RNS +2.02% Up
11:19 02-Dec-2015 VER Vernalis Results of Annual General Meeting RNS +2.83% Up
07:00 02-Dec-2015 VER AGM Statement RNS +2.83% Up
16:54 01-Dec-2015 VER Holding(s) in Company RNS +3.51% Up

 Page 1 of 3

| 1 | 2 | 3 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.





Company Information
Updated Monthly
Company address 100 Berkshire Place, Wharfedale Road, Winnersh, RG41 5RD, United Kingdom
Company website http://www.vernalis.com
Market cap(in millions)* £ 219.95
Listing/Admission to trading 27 Apr 2012
Trading service SETS
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
02-May-16
FTSE index FTSE AIM All-Share,FTSE AIM 100,FTSE AIM UK 50,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AMSM
MiFID Status MTF
Exchange market size 10,000
SEDOL B3Y5L75
ISIN number GB00B3Y5L754


Start trading your favourite asset CFDs!
Carries risk of capital loss



VERNALIS share news analysis (VER)